Hudson Frederick M.
SEC insider (Form 3/4/5 filer). CIK 0001438462. Director at SUPERNUS PHARMACEUTICALS, INC. (SUPN) and 1 other issuer. 18 reported Form 4/5 transactions since Sep 2024; latest on Mar 12, 2026. Located in ROCKVILLE, MD.
Companies Hudson Frederick M. has filed insider reports for
- SUPERNUS PHARMACEUTICALS, INC. (SUPN): Director
- scPharmaceuticals Inc. (SCPH): Director
Hudson Frederick M.
CIK: 0001438462
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Mar 12, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
SaleDirect5.4K shares at avg. $50.61$272K - Feb 24, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
DispositionDirectRestricted Stock Unit
4.5K shares- - Feb 24, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirect4.5K shares- - Feb 18, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Unit
3K shares- - Feb 18, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirectDirector Stock Option (Right to Buy)
5K shares- - Jan 9, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
ExerciseDirect15K shares at avg. $12.98$195K - Oct 7, 2025SCPH
scPharmaceuticals Inc.
DispositionDirectStock Option (Right to Buy)
30K shares- - Oct 7, 2025SCPH
scPharmaceuticals Inc.
DispositionDirectStock Option (Right to Buy)
6.1K shares- - Oct 7, 2025SCPH
scPharmaceuticals Inc.
DispositionDirectStock Option (Right to Buy)
16.3K shares- - Oct 7, 2025SCPH
scPharmaceuticals Inc.
DispositionDirectStock Option (Right to Buy)
19.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 12, 2026 |  SUPN SUPERNUS PHARMACEUTICALS, INC. | Sale | 5,369 | $50.61 | $271,725 | Direct |
| Feb 24, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Disposition Restricted Stock Unit | 4,475 | - | - | Direct |
| Feb 24, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award | 4,475 | - | $0 | Direct |
| Feb 18, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award Restricted Stock Unit | 2,989 | - | - | Direct |
| Feb 18, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award Director Stock Option (Right to Buy) | 4,977 | - | - | Direct |
| Jan 9, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Exercise | 15,000 | $12.98 | $194,700 | Direct |
| Oct 7, 2025 |  SCPH scPharmaceuticals Inc. | Disposition Stock Option (Right to Buy) | 30,000 | - | - | Direct |
| Oct 7, 2025 | SCPH scPharmaceuticals Inc. | Disposition Stock Option (Right to Buy) | 6,124 | - | - | Direct |
| Oct 7, 2025 | SCPH scPharmaceuticals Inc. | Disposition Stock Option (Right to Buy) | 16,300 | - | - | Direct |
| Oct 7, 2025 | SCPH scPharmaceuticals Inc. | Disposition Stock Option (Right to Buy) | 19,750 | - | - | Direct |
1-10 of 18 transactions